Advanced search
Publication Cover
Expert Review of Endocrinology & Metabolism Volume 8, 2013 - Issue 3
Submit an article Journal homepage
59
Views
8
CrossRef citations to date
0
Altmetric
Editorial

Statin therapy and new-onset diabetes: an attempt at recommendations

Maciej Banach Chair of Nephrology and Hypertension, Department of Hypertension, WAM University Hospital in Lodz, Medical University of Lodz, Zeromskiego 113; Lodz 90-549, Poland. [email protected]
&
Dimitri P Mikhailidis Department of Clinical Biochemistry, Royal Free Hospital campus, University College London Medical School, University College London (UCL), London, UK
Pages 213-216 | Published online: 10 Jan 2014

References

  • Banach M, Malodobra-Mazur M, Gluba A, Katsiki N, Rysz J, Dobrzyn A. Statin therapy and new-onset diabetes: molecular mechanisms and clinical relevance. Curr. Pharm. Des. PMID: 23278491 (2013) (Epub ahead of print).
  • Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Dyslipidaemia of obesity, metabolic syndrome and Type 2 diabetes mellitus: the case for residual risk reduction after statin treatment. Open Cardiovasc. Med. J. 5, 24–34 (2011).
  • Otocka-Kmiecik A, Rysz J, Banach M. Prodiabetic effect of statins – do we know the mechanisms of this phenomenon? Postepy Biochem. 58(2), 195–203 (2012).
  • Mikhailidis DP, Elisaf M, Rizzo M et al. “European panel on low density lipoprotein (LDL) subclasses”: a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses. Curr. Vasc. Pharmacol. 9(5), 533–571 (2011).
  • Hsueh WA, Quiñones MJ. Role of endothelial dysfunction in insulin resistance. Am. J. Cardiol. 92(4A), 10J–17J (2003).
  • Zoungas S, Patel A. Cardiovascular outcomes in Type 2 diabetes: the impact of preventative therapies. Ann. NY Acad. Sci. 1212, 29–40 (2010).
  • Sukhija R, Prayaga S, Marashdeh M et al. Effect of statins on fasting plasma glucose in diabetic and nondiabetic patients. J. Investig. Med. 57(3), 495–499 (2009).
  • Banach M, Mikhailidis DP, Kjeldsen SE, Rysz J. Time for new indications for statins? Med. Sci. Monit. 15(12), MS1–MS5 (2009).
  • Katsiki N, Banach M. Statin use and risk of diabetes mellitus in postmenopausal women. Clin. Lipidol. 7 267–270 (2012).
  • Rizzo M, Mikhailidis DP. Lipoprotein alterations and reduced growth hormone secretion: relationships with obesity and cardiovascular risk. Clin. Endocrinol. (Oxf.) 76(2), 177–178 (2012).
  • Mäuser W, Perwitz N, Meier B, Fasshauer M, Klein J. Direct adipotropic actions of atorvastatin: differentiation state-dependent induction of apoptosis, modulation of endocrine function, and inhibition of glucose uptake. Eur. J. Pharmacol. 564(1–3), 37–46 (2007).
  • McGuire TF, Xu XQ, Corey SJ, Romero GG, Sebti SM. Lovastatin disrupts early events in insulin signaling: a potential mechanism of lovastatin’s anti-mitogenic activity. Biochem. Biophys. Res. Commun. 204(1), 399–406 (1994).
  • Takaguri A, Satoh K, Itagaki M, Tokumitsu Y, Ichihara K. Effects of atorvastatin and pravastatin on signal transduction related to glucose uptake in 3T3L1 adipocytes. J. Pharmacol. Sci. 107(1), 80–89 (2008).
  • Nakata M, Nagasaka S, Kusaka I, Matsuoka H, Ishibashi S, Yada T. Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control. Diabetologia 49(8), 1881–1892 (2006).
  • Metz SA, Rabaglia ME, Stock JB, Kowluru A. Modulation of insulin secretion from normal rat islets by inhibitors of the post-translational modifications of GTP-binding proteins. Biochem. J. 295 (Pt 1), 31–40 (1993).
  • Yada T, Nakata M, Shiraishi T, Kakei M. Inhibition by simvastatin, but not pravastatin, of glucose-induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L-type Ca2+ channels in rat islet beta-cells. Br. J. Pharmacol. 126(5), 1205–1213 (1999).
  • Xia F, Xie L, Mihic A et al. Inhibition of cholesterol biosynthesis impairs insulin secretion and voltage-gated calcium channel function in pancreatic beta-cells. Endocrinology 149(10), 5136–5145 (2008).
  • Stepien M, Wlazel RN, Paradowski M et al. Serum concentrations of adiponectin, leptin, resistin, ghrelin and insulin and their association with obesity indices in obese normo- and hyper-tensive patients – pilot study. Arch. Med. Sci. 8(3), 431–436 (2012).
  • Stepien M, Rosniak-Bak K, Paradowski M et al. Waist circumference, ghrelin and selected adipose tissue-derived adipokines as predictors of insulin resistance in obese patients: preliminary results. Med. Sci. Monit. 17(11), PR13–PR18 (2011).
  • Katsiki N, Banach M. Statins and the risk of diabetes: the debate. Arch. Intern. Med. 172(11), 895–896; author reply 896 (2012).
  • Sattar N, Preiss D, Murray HM et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 375(9716), 735–742 (2010).
  • Ray KK, Seshasai SR, Erqou S et al. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch. Intern. Med. 170(12), 1024–1031 (2010).
  • Wright JM. Do statins have a role in primary prevention? An update. Ther. Lett. 77, 1–2 (2010).
  • Rajpathak SN, Kumbhani DJ, Crandall J, Barzilai N, Alderman M, Ridker PM. Statin therapy and risk of developing Type 2 diabetes: a meta-analysis. Diabetes Care 32, 1924–1929 (2009).
  • Waters DD, Ho JE, DeMicco DA et al. Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials. J. Am. Coll. Cardiol. 57(14), 1535–1545 (2011).
  • Preiss D, Seshasai SR, Welsh P et al. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA 305(24), 2556–2564 (2011).
  • Ridker PM, Pradhan A, MacFadyen JG, Libby P, Glynn RJ. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet 380(9841), 565–571 (2012).
  • Watts GF, Ooi EM. Balancing the cardiometabolic benefits and risks of statins. Lancet 380(9841), 541–543 (2012).
  • Waters DD, Ho JE, Boekholdt SM et al. Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes. J. Am. Coll. Cardiol. 61(2), 148–152 (2013).
  • Wang KL, Liu CJ, Chao TF et al. Statins, risk of diabetes, and implications on outcomes in the general population. J. Am. Coll. Cardiol. 60(14), 1231–1238 (2012).
  • Culver AL, Ockene IS, Balasubramanian R et al. Statin use and risk of diabetes mellitus in postmenopausal women in the Women’s Health Initiative. Arch. Intern. Med. 172(2), 144–152 (2012).
  • Taylor F, Huffman MD, Macedo AF et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 1, CD004816 (2013).
  • Athyros VG, Mikhailidis DP. Pharmacotherapy: statins and new-onset diabetes mellitus – a matter for debate. Nat. Rev. Endocrinol. 8(3), 133–134 (2012).
  • Athyros VG, Elisaf MS, Alexandrides T et al.; Assessing the Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT) Collaborative Group. Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis. Angiology 63(5), 358–366 (2012).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.